Literature DB >> 21931170

Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy.

Elisa Fassone1, Jan-Willem Taanman, Iain P Hargreaves, Neil J Sebire, Maureen A Cleary, Michael Burch, Shamima Rahman.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is frequently fatal in infancy. Mitochondrial disease causing infantile HCM is characterised by extreme biochemical and genetic heterogeneity, but deficiency of respiratory chain complex I is observed relatively frequently. Identification of the precise genetic basis has prognostic implications for the likelihood of neurological involvement.
OBJECTIVE: The authors' objective is to report two heterozygous missense mutations in the NDUFAF1 gene as a cause of fatal infantile HCM in a patient with isolated complex I deficiency.
METHODS: The authors investigated a cohort of 30 paediatric patients with complex I deficiency using biochemical and genetic approaches. The patients were clinically heterogeneous; phenotypes included HCM, Leigh syndrome, other encephalomyopathies and multisystem disease. Complex I assembly was evaluated using Blue Native polyacrylamide gel electrophoresis.
RESULTS: Sequence analysis of NDUFAF1 revealed compound heterozygous missense mutations (c.631C>T;p.Arg211Cys and c.733G>A;p.Gly245Arg) in one patient with fatal infantile HCM. These changes were absent in 240 ethnically matched control alleles. No NDUFAF1 mutations were observed in the remaining patients. Functional studies demonstrated a severe reduction in NDUFAF1 protein in Western blots of patient fibroblasts and accumulation of abnormal complex I assembly intermediates on Blue Native polyacrylamide gel electrophoresis.
CONCLUSIONS: The authors report a case of fatal infantile HCM caused by missense mutations in NDUFAF1 associated with complex I misassembly. Establishing a genetic diagnosis in mitochondrial cardiomyopathy is challenging and achieved in only a minority of cases because of complex genetics. A precise genetic diagnosis is important to provide accurate prognostic and genetic counselling advice regarding recurrence risks and to guide future reproductive options.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931170     DOI: 10.1136/jmedgenet-2011-100340

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Widening the Heterogeneity of Leigh Syndrome: Clinical, Biochemical, and Neuroradiologic Features in a Patient Harboring a NDUFA10 Mutation.

Authors:  Francesca Minoia; Marta Bertamino; Paolo Picco; Mariasavina Severino; Andrea Rossi; Chiara Fiorillo; Carlo Minetti; Claudia Nesti; Filippo Maria Santorelli; Maja Di Rocco
Journal:  JIMD Rep       Date:  2017-03-01

Review 2.  Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.

Authors:  Maurizio Forte; Silvia Palmerio; Franca Bianchi; Massimo Volpe; Speranza Rubattu
Journal:  J Mol Med (Berl)       Date:  2019-03-12       Impact factor: 4.599

Review 3.  Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs.

Authors:  Vincenzo Tragni; Guido Primiano; Albina Tummolo; Lucas Cafferati Beltrame; Gianluigi La Piana; Maria Noemi Sgobba; Maria Maddalena Cavalluzzi; Giulia Paterno; Ruggiero Gorgoglione; Mariateresa Volpicella; Lorenzo Guerra; Domenico Marzulli; Serenella Servidei; Anna De Grassi; Giuseppe Petrosillo; Giovanni Lentini; Ciro Leonardo Pierri
Journal:  Molecules       Date:  2022-05-29       Impact factor: 4.927

4.  Mutations in Complex I Assembly Factor TMEM126B Result in Muscle Weakness and Isolated Complex I Deficiency.

Authors:  Laura Sánchez-Caballero; Benedetta Ruzzenente; Lucas Bianchi; Zahra Assouline; Giulia Barcia; Metodi D Metodiev; Marlène Rio; Benoît Funalot; Mariël A M van den Brand; Sergio Guerrero-Castillo; Joery P Molenaar; David Koolen; Ulrich Brandt; Richard J Rodenburg; Leo G Nijtmans; Agnès Rötig
Journal:  Am J Hum Genet       Date:  2016-06-30       Impact factor: 11.025

Review 5.  Cardiac complications in inherited mitochondrial diseases.

Authors:  Mohaddeseh Behjati; Mohammad Reza Sabri; Masood Etemadi Far; Majid Nejati
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

Review 6.  Dynamics of Human Mitochondrial Complex I Assembly: Implications for Neurodegenerative Diseases.

Authors:  Gabriele Giachin; Romain Bouverot; Samira Acajjaoui; Serena Pantalone; Montserrat Soler-López
Journal:  Front Mol Biosci       Date:  2016-08-22

7.  Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission.

Authors:  Rojeen Shahni; Catherine M Cale; Glenn Anderson; Laura D Osellame; Sophie Hambleton; Thomas S Jacques; Yehani Wedatilake; Jan-Willem Taanman; Emma Chan; Waseem Qasim; Vincent Plagnol; Annapurna Chalasani; Michael R Duchen; Kimberly C Gilmour; Shamima Rahman
Journal:  Brain       Date:  2015-06-29       Impact factor: 13.501

Review 8.  Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes.

Authors:  Cristina Mazzaccara; Bruno Mirra; Ferdinando Barretta; Martina Caiazza; Barbara Lombardo; Olga Scudiero; Nadia Tinto; Giuseppe Limongelli; Giulia Frisso
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 6.208

9.  Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.

Authors:  Xiao Zuo; Daoyin Dong; Miao Sun; Huiqi Xie; Y James Kang
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy.

Authors:  Edward T Chouchani; Carmen Methner; Guido Buonincontri; Chou-Hui Hu; Angela Logan; Stephen J Sawiak; Michael P Murphy; Thomas Krieg
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.